Medical Devices News and Research

RSS

Health Research Institute presents top 10 issues in the upcoming year

PricewaterhouseCoopers' Health Research Institute's Top 10 Health Industry Issues in 2010, puts healthcare cost control at the head of the list as the overarching theme for the year ahead.

17 Dec 2009

Unilife Medical Solutions to construct new global headquarters and commercial production facility

Unilife Medical Solutions Limited (Unilife or the Company) today announced the signing of agreements for the construction of its new global headquarters and commercial production facility in York, Pennsylvania.

17 Dec 2009

KarmelSonix selects Blackfin digital signal processors from Analog Devices

Analog Devices, Inc. announced today that KarmelSonix, pioneers in medical device development for asthma management, have chosen Analog Devices’ Blackfin digital signal processors and advanced signal chain components to power its products.

17 Dec 2009

Medical device makers divided over reduced tax

Medical device makers are still split over a reduced tax in the Senate health bill, Roll Call reports.

16 Dec 2009

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

TSO3 Inc. and 3M (MMM) today announced that an agreement has been reached for 3M to be the exclusive supplier and distributor of TSO3's STERIZONE(R) 125L+ Sterilizer. The partnership with TSO3, an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, will include new cycles to reach acute care facilities through 3M's global sales channel.

16 Dec 2009

Ouroboros Medical receives approval to market its spinal fusion product in Europe

Ouroboros Medical, Inc., an early stage medical device company focused on developing minimally invasive spine products for degenerated disc disease, has received approval to market Ouroboros’s spinal fusion product in Europe.

16 Dec 2009

NREF supports new post-residency fellowship grant program

The NREF has reached an agreement with Codman & Shurtleff, Inc. to provide funding to the NREF in support of the Foundation's new post-residency fellowship grant program.

16 Dec 2009

FDA grants approval to market InterSol platelet additive solution

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution.

15 Dec 2009

Flextronics acquires SloMedical S.R.O

Flextronics today announced that it has completed the previously announced acquisition of SloMedical S.R.O., a leading European manufacturer of disposable medical devices ranging from tubing sets to complex devices for minimally-invasive surgery.

15 Dec 2009

FDA opens third city post in Latin America

As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the U.S. Food and Drug Administration today announced the opening of its Mexico City post. This is the Agency's third post in Latin America and its tenth international post in the past 13 months.

15 Dec 2009

CALSTAR 6 recognised with the "Thermal Angel Lifesaver of the Year Award"

Estill Medical Technologies, Inc., a family-owned Texas company that produces the Thermal Angel Blood and IV Fluid Infusion Warmer, a patented medical device being utilized by U.S. hospitals, military and emergency responders to lessen the effects of fluid-induced hypothermia, named the CALSTAR 6 Unit of South Lake Tahoe as the first-ever recipient of their "Thermal Angel Lifesaver of the Year Award."

15 Dec 2009

Patent for novel method of cutting tissue materials for use in implantable devices issued

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that the United States Patent and Trademark Office has issued patent number 7,594,974 regarding a novel method of cutting tissue materials for use in implantable devices.

15 Dec 2009

Springer and BMES to publish 'Cardiovascular Engineering and Technology' journal

Springer and the Biomedical Engineering Society (BMES) have founded a new journal Cardiovascular Engineering and Technology (CVET). CVET is a forum for research on all aspects of cardiovascular physiology and medical treatment.

15 Dec 2009

Hospitals to find acceptable alternatives to STERIS System 1 sterile processing system

In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.

15 Dec 2009

Alcon signs definitive agreement to acquire Optonol

Alcon announced today that it has entered into a definitive agreement to acquire Optonol, Ltd., a medical device company that develops, manufactures and markets novel miniature surgical implants used to lower intraocular pressure (IOP) in patients with glaucoma.

14 Dec 2009

FDA grants EUA for DxNA’s 2009 H1N1 influenza virus diagnostic test

DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA's GeneSTAT(TM) detection platform.

14 Dec 2009

Hansen Medical enters into Confidential Settlement Agreement with Luna Innovations

Hansen Medical, Inc. announced today that it has entered into a Confidential Settlement Agreement (the "Settlement Agreement") with Luna Innovations Incorporated (NASDAQ: LUNA) and its wholly-owned subsidiary, Luna Technologies, Inc.

12 Dec 2009

"Checklists" for evaluating comparative effectiveness research

A new report released today by the National Pharmaceutical Council (NPC) provides guidance in the evaluation of comparative effectiveness research (CER), including easy-to-use "checklists" that help make sure such studies can be used to improve the dialogue between health care providers and patients, as well as better inform health care decision-making.

11 Dec 2009

Boston Scientific declares public offering of $2 billion senior notes

Boston Scientific Corporation today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior notes under the Company's shelf registration statement.

10 Dec 2009

Biomoda, Christiana Care Health System partner in study of CyPath lung cancer diagnostic test

Cancer diagnostics company Biomoda, Inc. today announced that The Helen F. Graham Cancer Center associated with Christiana Care Health System, a screening site for the International Early Lung Cancer Program (I-ELCAP), will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath® assay, an early-stage diagnostic test for lung cancer.

10 Dec 2009